A Podcast Series

Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by the increased destruction of platelets. It is a highly heterogeneous disease with variable clinical manifestations. Several new therapies have been introduced in recent years to target disease pathophysiology. Choice of therapy is based on shared decision-making with patients. In these 2 podcasts, an advanced practice provider and expert faculty discuss factors associated with ITP and strategies for managing initial and refractory ITP. Considerations for individualizing treatment and special populations are discussed. Listeners can earn a total of 0.50 credit hours.

If you have already listened to the podcasts, use the buttons below to access the post-test and evaluation for each and receive your certificate.


Hanny Al-Samkari, MD Assistant Professor Harvard Medical SchoolAttending Hematologist and Clinical InvestigatorDivision of Hematology OncologyMassachusetts General HospitalBoston, Massachusetts

Christopher Nelson, ACNP-BC, MBA Nurse PractitionerHematology and OncologyAvera Cancer InstituteAvera St. Luke's HospitalAberdeen, South Dakota

Development Widget